118 related articles for article (PubMed ID: 38718446)
1. Effect and mechanism of C-terminal cysteine on the properties of HEV p222 protein.
Liu Z; Zhang Z; Yang L; Zhang Y; Li D; Zhang Q; Niu C; Zhang B; Zhai Y; Wang Z
Virology; 2024 Jul; 595():110091. PubMed ID: 38718446
[TBL] [Abstract][Full Text] [Related]
2. Role of the C-terminal cysteines in virus-like particle formation and oligomerization of the hepatitis E virus ORF2 truncated proteins.
Liu Z; Behloul N; Baha S; Wei W; Tao W; Zhang T; Li W; Shi R; Meng J
Virology; 2020 May; 544():1-11. PubMed ID: 32174509
[TBL] [Abstract][Full Text] [Related]
3. [Interface domain of hepatitis E virus capsid protein homodimer].
Li SW; He ZQ; Wang YB; Chen YX; Liu RS; Lin J; Gu Y; Zhang J; Xia NS
Sheng Wu Gong Cheng Xue Bao; 2004 Jan; 20(1):90-8. PubMed ID: 16108497
[TBL] [Abstract][Full Text] [Related]
4. Molecular modeling and analysis of hepatitis E virus (HEV) papain-like cysteine protease.
Parvez MK; Khan AA
Virus Res; 2014 Jan; 179():220-4. PubMed ID: 24321124
[TBL] [Abstract][Full Text] [Related]
5. Structural characterization of recombinant hepatitis E virus ORF2 proteins in baculovirus-infected insect cells.
Robinson RA; Burgess WH; Emerson SU; Leibowitz RS; Sosnovtseva SA; Tsarev S; Purcell RH
Protein Expr Purif; 1998 Feb; 12(1):75-84. PubMed ID: 9473460
[TBL] [Abstract][Full Text] [Related]
6. New insights into the ORF2 capsid protein, a key player of the hepatitis E virus lifecycle.
Ankavay M; Montpellier C; Sayed IM; Saliou JM; Wychowski C; Saas L; Duvet S; Aliouat-Denis CM; Farhat R; de Masson d'Autume V; Meuleman P; Dubuisson J; Cocquerel L
Sci Rep; 2019 Apr; 9(1):6243. PubMed ID: 31000788
[TBL] [Abstract][Full Text] [Related]
7. Antigenic Characterization of ORF2 and ORF3 Proteins of Hepatitis E Virus (HEV).
Pezzoni G; Stercoli L; Pegoiani E; Brocchi E
Viruses; 2021 Jul; 13(7):. PubMed ID: 34372591
[TBL] [Abstract][Full Text] [Related]
8. Production of capsid proteins of rat hepatitis E virus in Escherichia coli and characterization of self-assembled virus-like particles.
Kobayashi T; Takahashi M; Ohta S; Nagashima S; Primadharsini PP; Mulyanto ; Kunita S; Murata K; Okamoto H
Virus Res; 2021 Sep; 302():198483. PubMed ID: 34146611
[TBL] [Abstract][Full Text] [Related]
9. Generation of hepatitis E virus-like particles of two new genotypes G5 and G6 and comparison of antigenic properties with those of known genotypes.
Li TC; Kataoka M; Takahashi K; Yoshizaki S; Kato T; Ishii K; Takeda N; Mishiro S; Wakita T
Vet Microbiol; 2015 Jul; 178(1-2):150-7. PubMed ID: 25934534
[TBL] [Abstract][Full Text] [Related]
10. Essential elements of the capsid protein for self-assembly into empty virus-like particles of hepatitis E virus.
Li TC; Takeda N; Miyamura T; Matsuura Y; Wang JC; Engvall H; Hammar L; Xing L; Cheng RH
J Virol; 2005 Oct; 79(20):12999-3006. PubMed ID: 16189002
[TBL] [Abstract][Full Text] [Related]
11. Disulfide bond formation in the herpes simplex virus 1 UL6 protein is required for portal ring formation and genome encapsidation.
Albright BS; Nellissery J; Szczepaniak R; Weller SK
J Virol; 2011 Sep; 85(17):8616-24. PubMed ID: 21593161
[TBL] [Abstract][Full Text] [Related]
12. Progress in the Production of Virus-Like Particles for Vaccination against Hepatitis E Virus.
Mazalovska M; Kouokam JC
Viruses; 2020 Jul; 12(8):. PubMed ID: 32751441
[TBL] [Abstract][Full Text] [Related]
13. Identification of B-cell epitopes in the capsid protein of avian hepatitis E virus (avian HEV) that are common to human and swine HEVs or unique to avian HEV.
Guo H; Zhou EM; Sun ZF; Meng XJ; Halbur PG
J Gen Virol; 2006 Jan; 87(Pt 1):217-223. PubMed ID: 16361434
[TBL] [Abstract][Full Text] [Related]
14. Characterization of self-assembled virus-like particles of dromedary camel hepatitis e virus generated by recombinant baculoviruses.
Zhou X; Kataoka M; Liu Z; Takeda N; Wakita T; Li TC
Virus Res; 2015 Dec; 210():8-17. PubMed ID: 26160190
[TBL] [Abstract][Full Text] [Related]
15. An intramolecular disulfide bond between conserved extracellular cysteines in the gonadotropin-releasing hormone receptor is essential for binding and activation.
Cook JV; Eidne KA
Endocrinology; 1997 Jul; 138(7):2800-6. PubMed ID: 9202220
[TBL] [Abstract][Full Text] [Related]
16. Characterization of self-assembled virus-like particles of ferret hepatitis E virus generated by recombinant baculoviruses.
Yang T; Kataoka M; Ami Y; Suzaki Y; Kishida N; Shirakura M; Imai M; Asanuma H; Takeda N; Wakita T; Li TC
J Gen Virol; 2013 Dec; 94(Pt 12):2647-2656. PubMed ID: 24018315
[TBL] [Abstract][Full Text] [Related]
17. Unique disulfide bond structures found in ST8Sia IV polysialyltransferase are required for its activity.
Angata K; Yen TY; El-Battari A; Macher BA; Fukuda M
J Biol Chem; 2001 May; 276(18):15369-77. PubMed ID: 11279095
[TBL] [Abstract][Full Text] [Related]
18. A ribavirin-induced ORF2 single-nucleotide variant produces defective hepatitis E virus particles with immune decoy function.
Meister TL; Brüggemann Y; Nocke MK; Ulrich RG; Schuhenn J; Sutter K; Gömer A; Bader V; Winklhofer KF; Broering R; Verhoye L; Meuleman P; Vondran FWR; Camuzet C; Cocquerel L; Todt D; Steinmann E
Proc Natl Acad Sci U S A; 2022 Aug; 119(34):e2202653119. PubMed ID: 35969792
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis E Virus Lifecycle and Identification of 3 Forms of the ORF2 Capsid Protein.
Montpellier C; Wychowski C; Sayed IM; Meunier JC; Saliou JM; Ankavay M; Bull A; Pillez A; Abravanel F; Helle F; Brochot E; Drobecq H; Farhat R; Aliouat-Denis CM; Haddad JG; Izopet J; Meuleman P; Goffard A; Dubuisson J; Cocquerel L
Gastroenterology; 2018 Jan; 154(1):211-223.e8. PubMed ID: 28958858
[TBL] [Abstract][Full Text] [Related]
20. Design and immunogenicity analysis of the combined vaccine against zoonotic hepatitis E and foot-and-mouth disease.
Liu Z; Behloul N; Baha S; Wei W; Shi R; Meng J
Vaccine; 2019 Oct; 37(46):6922-6930. PubMed ID: 31604580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
